Cargando…

Drug Resistance and Novel Therapies in Cancers in 2019

Detalles Bibliográficos
Autor principal: Wang, Zhixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926476/
https://www.ncbi.nlm.nih.gov/pubmed/33672119
http://dx.doi.org/10.3390/cancers13040924
_version_ 1783659475136151552
author Wang, Zhixiang
author_facet Wang, Zhixiang
author_sort Wang, Zhixiang
collection PubMed
description
format Online
Article
Text
id pubmed-7926476
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79264762021-03-04 Drug Resistance and Novel Therapies in Cancers in 2019 Wang, Zhixiang Cancers (Basel) Editorial MDPI 2021-02-23 /pmc/articles/PMC7926476/ /pubmed/33672119 http://dx.doi.org/10.3390/cancers13040924 Text en © 2021 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Wang, Zhixiang
Drug Resistance and Novel Therapies in Cancers in 2019
title Drug Resistance and Novel Therapies in Cancers in 2019
title_full Drug Resistance and Novel Therapies in Cancers in 2019
title_fullStr Drug Resistance and Novel Therapies in Cancers in 2019
title_full_unstemmed Drug Resistance and Novel Therapies in Cancers in 2019
title_short Drug Resistance and Novel Therapies in Cancers in 2019
title_sort drug resistance and novel therapies in cancers in 2019
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926476/
https://www.ncbi.nlm.nih.gov/pubmed/33672119
http://dx.doi.org/10.3390/cancers13040924
work_keys_str_mv AT wangzhixiang drugresistanceandnoveltherapiesincancersin2019